Biomet acquisition vs. IPO

Quote
Anonymous said:
A sports medicine department, the extremities market leader, Depuy’s trauma line, the leading uni and revision knee systems to complement their leading primary...........
Click to expand...

...a declining but profitable bone stimulation business, a solid dental business, the biologics business, and the underlying IP and patents for everything.
 












Hardly, only the guys at the very top or maybe some of the line workers who held on for the stock options. I made my million when Dane took the co private. He told us way back when that he wanted to make us all millionaires. Maybe not as much as him but enough to retire on. Bring it On Z
 












Best case for Warsaw, gubermint says no to a deal that will give Zimmer almost 40 pct of the hip and knee market.

Worst case, say goodbye to a good chunk of those 4,600 jobs at the two companies in IN. Plus all the community jobs that live off the workers. The press announcement was all about Changes to Business Model and Efficiency. Thanks for dumping Warsaw into a permanent depression Dave and Jeff. Not that your tails will ever feel it.

I bet they decide to go direct by next spring. Mmmm. I think that was Serbo checking out Dodge Darts at Barts the other day. Something about "a perfectly respectable rep car".
 










































Anonymous said:
Deal hasn't closed yet, sh*t-for-brains
Click to expand...

J&J bought Synthes for 20x earnings value,
This deal is Zimmer buying Biomet for approx. 18x earnings,

Medtronics trades around 12x earnings
Boston Scientific trades around 17x earnings


This deal is as good as done. Maybe the numbers change a little over the next 9 months but these guys will make it happen. Zimmer is going to move to number 3 in market share jumping over Stryker, so Zimmer won't have to deal with selling-off anything like J&J had to with trauma.

Indiana is going to be a mess.
 






















































Top Bottom
Back
Quote